Fourth Quarter Revenue: $4 million, a decrease of 10% from $4.4 million in Q4 2023. Full Year Revenue: $14.2 million, a decrease of 15% from $16.7 million in 2023. Gross Margin (Q4 2024): 51%, up from ...
Management reiterated 2025 revenue guidance of $17 million to $18 million, which represents 24% growth at the midpoint over 2024. Horn stated, "Our guidance range assumes our customers will continue ...
REDWOOD CITY, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced the launch of its new ...
Good day, and welcome to the Seer, Inc. Second Quarter 2025 Earnings Conference Call. [Operator Instructions] Please note this event is being recorded. I would now like to turn the conference over to ...
Seer, Inc. reported its financial results for the first quarter of 2025, highlighting a revenue of $4.2 million, a 37% increase from the same period last year, driven by higher product and service ...
At ASHG, Seer showcased its Proteograph product suite which it claims delivers proteomic insights that complement and strengthen other forms of omics data. Through various sessions at the meeting, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback